NLME (Non-Linear Mixed Effects) Archives

Video

Today’s drug candidates are more complex than ever. But with development decisions on the line,…

Certara2025 年 2 月 12 日

Publication

CS-8635, a fixed-dose triple combination of olmesartan, amlodipine, and hydrochlorothiazide, was developed to address the…

Certara2013 年 4 月 1 日

Publication

Reviews of the productivity of the pharmaceutical industry have concluded that the current business model…

Certara2011 年 11 月 18 日

沪ICP备2022021526号

NLME (Non-Linear Mixed Effects)